← Back to context

Comment by adamredwoods

3 years ago

This is an mTOR inhibitor, I believe there are others already in clinical trials. I know PIK3 inhibitors are used to block some cancers. Most inhibitors stop cancer for "a while" but cancer cells have the ability to circumvent pathway disruptions.

https://en.wikipedia.org/wiki/Sirolimus

https://en.wikipedia.org/wiki/MTOR_inhibitors

PI3K inhibitors only work if the tumour tests positive for that special mutation.